Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2300078671Phase 4Recruiting
Phase 4, randomised, open-label trial in None comparing Dexmedetomidine group with Ciprofol group (2 arms). Primary endpoints: Proportion of time in target sedation range and Bradycardia and hypotension incidence and duration. Started Mar 2023; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2300078671.